Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05964413 |
|---|---|
| Brief Title: | Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum |
| First Submitted : | June 29, 2023 |
| First Submitted that Met QC Criteria : | July 24, 2023 |
| First Posted : | July 27, 2023 |
| Last Update Submitted that Met QC Criteria : | April 27, 2024 |
| Last Update Posted : | April 30, 2024 |